| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $65.3M | +91.7% |
| R&D Expense | $739K | +559.8% |
| SG&A Expense | $79.7M | -8.1% |
| Operating Income | -$86.5M | +28.0% |
| Interest Expense | $5.4M | +5.1% |
| Pre-tax Income | -$74.9M | +69.3% |
| Income Tax | $0 | — |
| Net Income | -$74.2M | +69.8% |
| EPS (Basic) | -$0.63 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $34.2M | -79.4% |
| Short-term Investments | $38.0M | — |
| Accounts Receivable | $3.1M | +18.4% |
| Current Assets | $88.5M | -50.5% |
| Total Assets | $234.1M | -23.4% |
| Current Liabilities | $26.9M | -11.8% |
| Long-term Debt | $76.2M | +6.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$44.5M | +17.5% |
| Investing Cash Flow | -$81.6M | -28.2% |
| Financing Cash Flow | -$5.1M | -101.8% |
| +81.4% |
| EPS (Diluted) | -$0.63 | +81.4% |
| Total Liabilities |
| $112.2M |
| -11.0% |
| Stockholders' Equity | $121.9M | -32.1% |